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The old controversy on universal screening for high blood pressure in childhood has intensified since the US 
Preventive Task Force recommended not to screen for hyper-
tension in asymptomatic children in 2013.1 The reasoning at 
the time was that “the current evidence is insufficient to assess 
the balance of benefits and harms in asymptomatic children 
and adolescents to prevent subsequent cardiovascular disease 
in adulthood.”1 Furthermore, the prevalence of hypertension in 
childhood was viewed as very low and the risk of false-positive 
results as too high.1 This view contrasts the recommendations 
by many medical experts and medical societies. Only recently 
the European Society of Hypertension published updated 
guidelines and recommended screening for high blood pres-
sure starting at the age of 3 years, with a  reevaluation in chil-
dren with prehypertensive values after 1 year.2 The argument 
that was put forward, considering the noninvasive, noncostly, 
and easy to perform measurement, is that “lack of evidence 
does not necessarily justify inaction.”2
The article published in this issue of Hypertension by 
Hao et al3 adds to the evidence and supports arguments for 
blood pressure screening in youth. Adopting a new approach 
to identify children who will develop high blood pressure in 
adulthood, the authors applied latent class analyses to iden-
tify clusters of individuals who develop similar blood pres-
sure trajectories from childhood into young adulthood using 
data from the Georgia Stress and Health Study, a longitudinal 
study on the development of cardiovascular disease. The anal-
yses were based on a minimum of 3 up to 16 blood pressure 
measurements per individual over a 23-year study period and 
provide prevalence data, differentiation of risk groups, and 
long-term effects of high blood pressure.
Prevalence of elevated blood pressure may be low in child-
hood compared with other cardiovascular risk factors, such 
as being overweight. However, the cutoff for hypertension 
in childhood is the 95% percentile of blood pressure by sex, 
age, and height, thus in theory population prevalence should 
be ≈5%. Five percent of the population can surely not be con-
sidered irrelevant. Literature presents a different picture, pro-
viding lower prevalence of hypertension in study populations 
of 0.8% to 4.5%4 when data rely on multiple blood pressure 
readings. Far higher prevalence is reported when studies 
report 1-time measurements.4 The higher prevalence can be 
explained with a high rate of false-positives and white coat 
hypertension, both strong arguments against 1-time screening, 
the lower rates point to a more complex issue. The primary 
question is how representative study populations and refer-
ence values actually are? It is common to use the US refer-
ence values based on the Fourth Report by the National High 
Blood Pressure Education Program Working Group on High 
Blood Pressure in Children when assessing high blood pres-
sure in children and adolescents.5 The data mainly stem from 
the National Health and Nutrition Examination Survey from 
1999 to 2000. The more recent German and Iranian blood 
pressure reference data in childhood underline the necessity 
of establishing population-specific reference values, as well 
as defining a healthy population when developing reference 
values.6,7 Second, the question is where to set the cutoff? 
The article by Hao et al3 presents differences in prevalence 
increase over time depending on the trajectory group rang-
ing from 42% hypertension in young adulthood in the high 
to 1.8% in the low blood pressure increase group, despite all 
participants being normotensive at the beginning of the study.3 
These results imply that cutoffs should be defined on the 
basis of long-term development of hypertension and its health 
consequences.
Experts agree on the high individual variability of blood 
pressure and risk of misclassification, but this also holds true 
for adult blood pressure measurements. The reality of 1-time 
readings because of the typical screening settings in child-
hood, like school health services or well-child doctor visits, 
can hardly be changed. A potential solution lies in the assess-
ment of blood pressure throughout childhood to capture and 
to diagnose the persistence or development of elevated blood 
pressure. Previous studies have demonstrated that high blood 
pressure in childhood tracks into adulthood and is a predic-
tor of adult hypertension8; however, this is not true for all. A 
more targeted approach in screening has been proposed taking 
cardiometabolic risk factors, such as overweight or parental 
history into account.9
The present article by Hao et al3 offers such a targeted 
approach. The authors identified 3 separate trajectories with 
different increase of blood pressure over of time. The high 
increase trajectory was more often found in men and individu-
als of African American ancestry, higher body mass index or 
lower socioeconomic status. The generalizability of the trajec-
tories and the associated characteristics to other populations 
needs to be confirmed in further research.
Only few studies, mainly in army recruits, have been 
able to investigate long-term health risks of adolescent high 
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blood pressure and yield an increased risk of adult cerebro-
vascular disease and mortality.10 Given that children cohorts 
investigating cardiovascular health have grown up to become 
adults,11 data on long-term impact of childhood blood pres-
sure on cardiovascular end points will become increasingly 
available. Until then intermediate end points, such as carotid 
intima media thickness or left ventricular hypertrophy, will 
need to serve the purpose. A considerable percentage of 
children with elevated blood pressure show increased left 
ventricular hypertrophy.12 The consortium of cardiovascu-
lar children cohorts observed that persistent elevated blood 
pressure was associated with higher increase of the carotid 
intima media thickness in adults compared with children 
without high blood pressure or with children in whom high 
blood pressure normalized across the observation period.13 
Indirectly, this result also points to a potential for preven-
tion. The association with carotid intima media thickness, an 
accepted subclinical indicator of atherosclerosis, has been 
seen in numerous cross-sectional studies14 and the potential 
of regression has been demonstrated.13 Although the evi-
dence of the absolute and relative importance of childhood 
blood pressure for cardiovascular end points is still rare, 
evidence for early changes to the cardiovascular system and 
long-term cardiovascular impact is mounting.
The presented study by Hao et al3 is even more valuable as 
the authors add to the evidence of the long-term health impact. 
They assessed the association between the different trajecto-
ries and objective intermediate outcomes of cardiovascular 
diseases: carotid intima media thickness and left ventricular 
hypertrophy. The results imply changes to function and struc-
ture of the cardiovascular system because of elevated blood 
pressure already at young age, especially in the high increase 
trajectory group.
Whichever stand one takes on the question of screen-
ing, authors generally agree on the need to further investi-
gate childhood factors of cardiovascular risk prediction and 
long-term health. The approach by Hao et al3 may facilitate 
the development of a targeted screening process and offer 
an additional indicator for clinicians to identify individu-
als at increased risk of end-organ damage. Certainly, there 
remains more work to be done. The reliability of the tra-
jectory assignment based on a few readings must be inves-
tigated, as well the time points at which blood pressure 
measurements are the most predictive of the trajectory and 
health impact. In addition, it seems worthwhile to define 
reference values and trajectories in different ethnic popula-
tions and to move from single risk factor analyses to risk 
cluster analyses in research, screening, and treatment, based 
on the knowledge that lifestyle risks tend to cluster, interact, 
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